Disease Markers / 2020 / Article / Fig 5

Research Article

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma

Figure 5

Downregulated UGP2 expression predicts a poor prognosis in HCC patients in the ZZU cohort. (a) Kaplan-Meier survival curves showing the correlation between UGP2 expression levels and the OS of HCC patients in the ZZU cohort. (b) Kaplan-Meier analysis revealed that OS was short in HCC patients in the ZZU cohort with low UGP2 expression levels regardless of the TNM stage. UGP2: uridine diphosphate-glucose pyrophosphorylase 2; HCC: hepatocellular carcinoma; OS: overall survival; TNM: tumour-node-metastasis.
(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.